全文获取类型
收费全文 | 3535篇 |
免费 | 192篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 124篇 |
妇产科学 | 46篇 |
基础医学 | 526篇 |
口腔科学 | 93篇 |
临床医学 | 268篇 |
内科学 | 813篇 |
皮肤病学 | 175篇 |
神经病学 | 215篇 |
特种医学 | 86篇 |
外科学 | 311篇 |
综合类 | 33篇 |
预防医学 | 198篇 |
眼科学 | 87篇 |
药学 | 292篇 |
中国医学 | 17篇 |
肿瘤学 | 415篇 |
出版年
2024年 | 4篇 |
2023年 | 46篇 |
2022年 | 83篇 |
2021年 | 111篇 |
2020年 | 56篇 |
2019年 | 85篇 |
2018年 | 119篇 |
2017年 | 89篇 |
2016年 | 87篇 |
2015年 | 91篇 |
2014年 | 137篇 |
2013年 | 144篇 |
2012年 | 270篇 |
2011年 | 248篇 |
2010年 | 190篇 |
2009年 | 130篇 |
2008年 | 199篇 |
2007年 | 235篇 |
2006年 | 259篇 |
2005年 | 211篇 |
2004年 | 202篇 |
2003年 | 202篇 |
2002年 | 186篇 |
2001年 | 29篇 |
2000年 | 28篇 |
1999年 | 29篇 |
1998年 | 31篇 |
1997年 | 31篇 |
1996年 | 23篇 |
1995年 | 26篇 |
1994年 | 16篇 |
1993年 | 13篇 |
1992年 | 16篇 |
1991年 | 11篇 |
1990年 | 15篇 |
1989年 | 18篇 |
1988年 | 8篇 |
1987年 | 11篇 |
1986年 | 9篇 |
1985年 | 12篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 9篇 |
1981年 | 2篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1976年 | 2篇 |
1974年 | 2篇 |
1967年 | 3篇 |
排序方式: 共有3748条查询结果,搜索用时 15 毫秒
51.
52.
53.
Hiroyuki Ito Mariko Abe Shinichi Antoku Takashi Omoto Masahiro Shinozaki Shinya Nishio 《Expert opinion on pharmacotherapy》2015,16(3):289-296
Objective: The clinical course > 6 months after the initiation of linagliptin in patients with type 2 diabetes was compared among the groups divided by their renal function.Methods: Two hundred and sixteen Japanese patients with type 2 diabetes treated with 5 mg once daily linagliptin were studied as the treated set. One hundred and forty-five subjects whose medications were not changed during the observation period were investigated as the full analysis set to assess the effectiveness. The subjects were divided into three groups based on an eGFR: eGFR ≥ 60, 59 – 45 and < 45 ml/min/1.73 m2. The parameters were analyzed separately in the patients receiving monotherapy and additional therapy of linagliptin.Results: The HbA1c (NGSP) levels significantly improved in both the patients receiving monotherapy and additional therapy. The changes in the HbA1c levels at 6 months were not significantly different between the groups with an eGFR ≥ 60, 59 – 45 and < 45 ml/min/1.73 m2 receiving monotherapy (?1.0, ?0.8 and ?0.8%, respectively). Similarly, those were not significantly different between the different groups receiving additional therapy (?0.6, ?0.5 and ?0.7%, respectively).Conclusions: Linagliptin is considered to be effective for patients with type 2 diabetes and renal impairment in the present analysis performed at our institution. 相似文献
54.
Overexpression of adenylate cyclase‐associated protein 2 is a novel prognostic marker in malignant melanoma 下载免费PDF全文
Yohei Masugi Keiji Tanese Katsura Emoto Ken Yamazaki Kathryn Effendi Takeru Funakoshi Mariko Mori Michiie Sakamoto 《Pathology international》2015,65(12):627-634
Malignant melanoma is one of the lethal malignant tumors worldwide. Previously we reported that adenylate cyclase‐associated protein 2 (CAP2), which is a well‐conserved actin regulator, was overexpressed in hepatocellular carcinoma; however, CAP2 expression in other clinical cancers remains unclear. The aim of the current study was to clarify the clinicopathological significance of CAP2 overexpression in malignant melanoma. Immunohistochemical analyses revealed that many melanoma cells exhibited diffuse cytoplasmic expression of CAP2, whereas no normal melanocytes showed detectable immunostaining for CAP2. A high level of CAP2 expression was seen in 14 of 50 melanomas and was significantly correlated with greater tumor thickness and nodular melanoma subtypes. In addition, a high level of CAP2 expression was associated with poor overall survival in univariate and multivariate analyses. For 13 patients, samples of primary and metastatic melanoma tissue were available: four patients exhibited higher levels of CAP2 expression in metastatic tumor compared to the primary site, whereas no patient showed lower levels of CAP2 expression in metastatic melanomas. Our findings show that CAP2 overexpression is a novel prognostic marker in malignant melanoma and that CAP2 expression seems to increase stepwise during tumor progression, suggesting the involvement of CAP2 in the aggressive behavior of malignant melanoma. 相似文献
55.
Chipanta David Pettifor Audrey Edwards Jessie Giovenco Danielle Topazian Hillary Mariko Bray Rachel M. Millington Monique C. Estill Janne Keiser Olivia Justman Jessica E. 《AIDS and behavior》2022,26(9):3068-3078
AIDS and Behavior - We aimed to measure social protection coverage among the general population, women and men living with HIV (WLHIV, MLHV), female and male sex workers (FSW, MSW), men who have... 相似文献
56.
Harada-Shiba M Takagi A Marutsuka K Moriguchi S Yagyu H Ishibashi S Asada Y Yokoyama S 《Circulation research》2004,95(9):945-952
We previously characterized the patients with autosomal recessive hypercholesterolemia (ARH) as having severe hypercholesterolemia and retarded plasma low-density lipoprotein (LDL) clearance despite normal LDL receptor (LDLR) function in their cultured fibroblasts, and we identified a mutation in the ARH locus in these patients. ARH protein is an adaptor protein of the LDL and reportedly modulates its internalization. We developed ARH knockout mice (ARH-/-) to study the function of this protein. Plasma total cholesterol level was higher in ARH-/- mice than that in wild-type mice (ARH+/+), being attributed to a 6-fold increase of LDL, whereas plasma lipoprotein was normal in the heterozygotes (ARH+/-). Clearance of 125I-LDL from plasma was retarded in ARH-/- mice, as much as that found in LDLR-/- mice. Fluorescence activity of the intravenously injected 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI)-LDL was recovered in the cytosol of the hepatocytes of ARH+/+ mice, but not in those of ARH-/- or LDLR-/- mice. Also, less radioactivity was recovered in the liver of ARH-/- or LDLR-/- mice when [3H]cholesteryl oleyl ether (CE)-labeled LDL was injected. In contrast, uptakes of [3H]CE-labeled LDL, 125I-LDL, and DiI-LDL were all normal or slightly subnormal when the ARH-/- hepatocytes were cultured. We thus concluded that the function of the hepatic LDLR is impaired in the ARH-/- mice in vivo, despite its normal function in vitro. These findings were consistent with the observations with the ARH homozygous patients and suggested that certain cellular environmental factors modulate the requirement of ARH for the LDLR function. 相似文献
57.
Kenya Nasu Etsuo Tsuchikane Osamu Katoh D Geoffrey Vince Renu Virmani Jean-Fran?ois Surmely Akira Murata Yoshihiro Takeda Tatsuya Ito Mariko Ehara Tetsuo Matsubara Mitsuyasu Terashima Takahiko Suzuki 《Journal of the American College of Cardiology》2006,47(12):2405-2412
OBJECTIVES: The goal of the present study was to compare the accuracy of in vivo tissue characterization obtained by intravascular ultrasound (IVUS) radiofrequency (RF) data analysis, known as Virtual Histology (VH), to the in vitro histopathology of coronary atherosclerotic plaques obtained by directional coronary atherectomy. BACKGROUND: Vulnerable plaque leading to acute coronary syndrome (ACS) has been associated with specific plaque composition, and its characterization is an important clinical focus. METHODS: Virtual histology IVUS images were performed before and after a single debulking cut using directional coronary atherectomy. Debulking region of in vivo histology image was predicted by comparing pre- and post-debulking VH images. Analysis of VH images with the corresponding tissue cross section was performed. RESULTS: Fifteen stable angina pectoris (AP) and 15 ACS patients were enrolled. The results of IVUS RF data analysis correlated well with histopathologic examination (predictive accuracy from all patients data: 87.1% for fibrous, 87.1% for fibro-fatty, 88.3% for necrotic core, and 96.5% for dense calcium regions, respectively). In addition, the frequency of necrotic core was significantly higher in the ACS group than in the stable AP group (in vitro histopathology: 22.6% vs. 12.6%, p = 0.02; in vivo virtual histology: 24.5% vs. 10.4%, p = 0.002). CONCLUSIONS: Correlation of in vivo IVUS RF data analysis with histopathology shows a high accuracy. In vivo IVUS RF data analysis is a useful modality for the classification of different types of coronary components, and may play an important role in the detection of vulnerable plaque. 相似文献
58.
Matsuyama S Shimonishi T Yoshimura H Higaki K Nasu K Toyooka M Aoki S Watanabe K Sugihara H 《World journal of gastroenterology : WJG》2008,14(18):2924-2927
A 79-year-old man was referred to this department due to the presence of extrahepatic bile duct carcinoma with a tumor at the left chest wall. The lesion was suspected to be a metastasis of bile duct carcinoma to the left wall, however, computed tomography (CT) revealed no regional lymph node or liver metastases. In addition, cytological and pathological examinations did not show malignancy. At the time of admission, the white blood cell count was 21 460 cells/μL (neutrophils, 18 240 cells/μL) and this elevated to 106 040 before death. In addition, serum granulocyte colony-stimulating factor (G-CSF) was elevated. At 28 d after admission, the patient died. An autopsy showed a poorly differentiated adenocarcinoma with sarcomatous change, which had slightly invaded into the pancreas around the bile duct, and was found in the distal bile duct with multiple metastases to the chest wall, lung, kidney, adrenal body, liver, mesentery, vertebra and mediastinal and para-aortic lymph nodes, without locoregional lymph node and liver metastasis. The cancer cells showed positive immunohistochemical staining for anti-G-CSF antibody. This is believed to be the first report of an extrahepatic bile duct carcinoma that produces G-CSF. Since G-CSF-producing carcinoma and sarcomatous change of the biliary tract leads to poor prognosis, early diagnosis and treatment are needed. When infection is ruled out, the G-CSF in serum should be examined. In addition, examinations such as bonescintigraphy and chest CT should also be considered for distant metastasis. 相似文献
59.
Natsuko Kobayashi Hiroko Iijima Toshifumi Tada Yoko Shibata Takashi Nishimura Takashi Kumada Mariko Hashimoto Akiko Higashiura Masahiro Yoshida Junko Nishimura Nobuhiro Aizawa Naoto Ikeda Tomoyuki Takashima Ryo Takata Hiroki Nishikawa Yoshinori Iwata Hirayuki Enomoto Seiichi Hirota Etsuro Hatano 《Ultrasound in medicine & biology》2021,47(4):941-946
The aim of the study described here was to clarify the diagnostic value of the fluttering sign, a new sign that characterizes hepatic hemangiomas in gray-scale ultrasonography (US). It refers to a phenomenon in which the speckled echogenicity inside the hemangioma changes continuously and seems to be moving. A total of 172 hemangiomas diagnosed with contrast-enhanced US were evaluated. The fluttering sign was found in 123 of 172 hemangiomas (71.5%). Its prevalence was significantly higher than that of the marginal strong echo (89/172, 51.7%, p < 0.001), posterior acoustic enhancement (103/172, 59.9%, p = 0.031) and chameleon sign (100/172, 58.1%, p = 0.013). In addition, the fluttering sign was observed significantly more frequently in mixed or hypo-echoic tumors than in hyper-echoic tumors (p < 0.001), relatively large tumors (p < 0.001) and tumors that were less than 5 cm from the body surface (p = 0.015). The fluttering sign in gray-scale US has great potential to be a new complementary sign for the diagnosis of hemangioma. 相似文献
60.